scholarly article | Q13442814 |
P50 | author | Deborah S Hasin | Q88070100 |
P2093 | author name string | Dvora Shmulewitz | |
Shaul Lev-Ran | |||
Ofir Livne | |||
P2860 | cites work | Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users | Q36562406 |
Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence | Q36932053 | ||
Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III. | Q37262248 | ||
Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. | Q37285983 | ||
Cannabis withdrawal in the United States: results from NESARC. | Q37421751 | ||
Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III. | Q37589721 | ||
Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980-1997. | Q38460008 | ||
Toking, Vaping, and Eating for Health or Fun: Marijuana Use Patterns in Adults, U.S., 2014. | Q38546980 | ||
US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991-1992 to 2012-2013. | Q38818527 | ||
Marijuana use and use disorders in adults in the USA, 2002-14: analysis of annual cross-sectional surveys | Q38824571 | ||
Trends of Cannabis Use Disorder in the Inpatient: 2002 to 2011. | Q38978983 | ||
The widening gender gap in marijuana use prevalence in the U.S. during a period of economic change, 2002-2014. | Q39162976 | ||
Is there evidence for symptoms of cannabis withdrawal in the national epidemiologic survey of alcohol and related conditions? | Q39320118 | ||
Cannabis withdrawal among non-treatment-seeking adult cannabis users | Q39355645 | ||
The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress | Q39732890 | ||
Cannabis Abuse Is Increasing and Associated with Increased Emergency Department Utilization in Gastroenterology Patients. | Q39953399 | ||
The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): reliability of substance use and psychiatric disorder modules in a general population sample | Q41375342 | ||
Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients | Q43270705 | ||
The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample | Q44487795 | ||
Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. | Q44883168 | ||
Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009. | Q44906514 | ||
The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample | Q44907459 | ||
Withdrawal symptoms do not predict relapse among subjects treated for cannabis dependence | Q46866973 | ||
Prevalence and correlates of "Vaping" as a route of cannabis administration in medical cannabis patients | Q47655800 | ||
Prolonged cannabis withdrawal in young adults with lifetime psychiatric illness | Q47789918 | ||
Marijuana use is associated with worse outcomes in symptom severity and violent behavior in patients with posttraumatic stress disorder | Q48072801 | ||
Abstinence symptoms following smoked marijuana in humans | Q48769083 | ||
Abstinence symptoms following oral THC administration to humans | Q48769102 | ||
Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. | Q52187770 | ||
An evaluation of the history of a marijuana withdrawal syndrome in a large population. | Q52274587 | ||
Clinical studies of cannabis tolerance and dependence | Q67501787 | ||
Marijuana withdrawal among adults seeking treatment for marijuana dependence | Q73312718 | ||
Risks and Benefits of Marijuana Use: A National Survey of U.S. Adults | Q90433297 | ||
Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions | Q22241102 | ||
Prevalence, Correlates, and Disability of Personality Disorders in the United States | Q22241105 | ||
Childhood maltreatment, 9/11 exposure, and latent dimensions of psychopathology: A test of stress sensitization | Q28396187 | ||
Cannabinoids for Medical Use | Q29391539 | ||
The cannabis withdrawal syndrome: current insights | Q30313180 | ||
Changes in Cannabis Potency Over the Last 2 Decades (1995-2014): Analysis of Current Data in the United States | Q31048322 | ||
Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment | Q31975155 | ||
Abstinence symptoms during withdrawal from chronic marijuana use. | Q33928980 | ||
The time course and significance of cannabis withdrawal | Q33967997 | ||
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers | Q34199610 | ||
The prevalence of cannabis withdrawal and its influence on adolescents' treatment response and outcomes: a 12-month prospective investigation | Q34252749 | ||
Quantifying the clinical significance of cannabis withdrawal | Q34437940 | ||
Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions | Q34456676 | ||
Prevalence, correlates, disability, and comorbidity of DSM-IV schizotypal personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions | Q34610068 | ||
Marijuana withdrawal syndrome in the animal model | Q34986723 | ||
The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample | Q35088286 | ||
Sociodemographic Characteristics of Cannabis Smokers and the Experience of Cannabis Withdrawal | Q35393346 | ||
Cannabis withdrawal predicts severity of cannabis involvement at 1-year follow-up among treated adolescents. | Q35623063 | ||
Review of the validity and significance of cannabis withdrawal syndrome | Q35932862 | ||
The cannabis withdrawal syndrome | Q36448206 | ||
The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample | Q36465741 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | toxicology | Q7218 |
P304 | page(s) | 170-177 | |
P577 | publication date | 2018-10-16 | |
P1433 | published in | Drug and Alcohol Dependence | Q5308875 |
P1476 | title | DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults | |
P478 | volume | 195 |
Q90221994 | Commentary on Terry-McElrath et al. (2019): Will persistent patterns of youth marijuana use compromise their futures? |
Q94562544 | Persistent cannabis use as an independent risk factor for violent behaviors in patients with schizophrenia |
Q91758790 | Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis |
Q92355700 | Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings |
Q64259354 | Trajectories of Dynamic Risk Factors as Predictors of Violence and Criminality in Patients Discharged From Mental Health Services: A Longitudinal Study Using Growth Mixture Modeling |